T0901317 is a potent PXR ligand: Implications for the biology ascribed to LXR

FEBS Letters

Volumn 581, Issue 9, 2007, Pages 1721-1726

  Mitro, Nico ^a,b   Vargas, Leo ^a   Romeo, Russell ^a   Koder, Alan ^a   Saez, Enrique ^a,b  

^a GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Ligand; Lipogenesis; Liver X receptor; Nuclear receptor

Indexed keywords

3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; CD36 ANTIGEN; LIVER X RECEPTOR; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; PREGNANE X RECEPTOR; SCAVENGER RECEPTOR;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; FATTY LIVER; GENE TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RECEPTOR BINDING;

ANTIGENS, CD36; ATP-BINDING CASSETTE TRANSPORTERS; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; DNA-BINDING PROTEINS; FATTY ACID SYNTHETASE COMPLEX; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; LUCIFERASES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; STEAROYL-COA DESATURASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SULFONAMIDES; TRANSFECTION;

ANIMALIA;

EID: 34247093820     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.03.047     Document Type: Article

References (32)

1. Kalaany N.Y., et al. LXRs regulate the balance between fat storage and oxidation. Cell. Metab. 1 (2005) 231-244
2. Willy P.J., Umesono K., Ong E.S., Evans R.M., Heyman R.A., and Mangelsdorf D.J. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 9 (1995) 1033-1045
3. Janowski B.A., Willy P.J., Devi T.R., Falck J.R., and Mangelsdorf D.J. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383 (1996) 728-731
4. Annicotte J.S., Schoonjans K., and Auwerx J. Expression of the liver X receptor alpha and beta in embryonic and adult mice. Anat. Rec. Part A 277 (2004) 312-316
5. Castrillo A., and Tontonoz P. Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation. Ann. Rev. Cell Dev. Biol. 20 (2004) 455-480
6. Schultz J.R., et al. Role of LXRs in control of lipogenesis. Genes Dev. 14 (2000) 2831-2838
7. Repa J.J., et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 14 (2000) 2819-2830
8. Laffitte B.A., Chao L.C., Li J., Walczak R., Hummasti S., Joseph S.B., Castrillo A., Wilpitz D.C., Mangelsdorf D.J., Collins J.L., Saez E., and Tontonoz P. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc. Natl. Acad. Sci. USA. 100 (2003) 5419-5424
9. Cao G., et al. Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis. J. Biol. Chem. 278 (2003) 1131-1136
10. Mitro N., Mak P.A., Vargas L., Godio C., Hampton E., Molteni V., Kreusch A., and Saez E. The nuclear receptor LXR is a glucose sensor. Nature 445 (2007) 219-223
11. Castrillo A., Joseph S.B., Marathe C., Mangelsdorf D.J., and Tontonoz P. Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J. Biol. Chem. 278 (2003) 10443-10449
12. Joseph S.B., Castrillo A., Laffitte B.A., Mangelsdorf D.J., and Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9 (2003) 213-219
13. Joseph S.B., et al. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119 (2004) 299-309
14. Collins J.L., et al. Identification of a Nonsteroidal Liver X Receptor Agonist through Parallel Array Synthesis of Tertiary Amines. J. Med. Chem. 45 (2002) 1963-1966
15. Joseph S.B., et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc. Natl. Acad. Sci. USA 99 (2002) 7604-7609
16. Tangirala R.K., et al. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc. Natl. Acad. Sci. USA 99 (2002) 11896-11901
17. Levin N., Bischoff E.D., Daige C.L., Thomas D., Vu C.T., Heyman R.A., Tangirala R.K., and Schulman I.G. Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 135-142
18. Schuster G.U., Parini P., Wang L., Alberti S., Steffensen K.R., Hansson G.K., Angelin B., and Gustafsson J.A. Accumulation of foam cells in liver X receptor-deficient mice. Circulation 106 (2002) 1147-1153
19. Grefhorst A., et al. Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice. Am. J. Physiol. Endocrinol. Metab. 289 (2005) E829-E838
20. Grefhorst A., et al. Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J. Biol. Chem. 277 (2002) 34182-34190
21. Chisholm J.W., Hong J., Mills S.A., and Lawn R.M. The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse. J. Lipid Res. 44 (2003) 2039-2048
22. Miao B., Zondlo S., Gibbs S., Cromley D., Hosagrahara V.P., Kirchgessner T.G., Billheimer J., and Mukherjee R. Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator. J. Lipid Res. 45 (2004) 1410-1417
23. Houck K.A., Borchert K.M., Hepler C.D., Thomas J.S., Bramlett K.S., Michael L.F., and Burris T.P. T0901317 is a dual LXR/FXR agonist. Mol. Gen. Metab. 83 (2004) 184-187
24. Stayrook K.R., Bramlett K.S., Savkur R.S., Ficorilli J., Cook T., Christe M.E., Michael L.F., and Burris T.P. Regulation of carbohydrate metabolism by the farnesoid X receptor. Endocrinology 146 (2005) 984-991
25. Zhou J., et al. A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway. J. Biol. Chem. 281 (2006) 15013-15020
26. Xie W., et al. Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature 406 (2000) 435-439
27. Kliewer S.A., et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92 (1998) 73-82
28. Janowski B.A., Grogan M.J., Jones S.A., Wisely G.B., Kliewer S.A., Corey E.J., and Mangelsdorf D.J. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc. Natl. Acad. Sci. USA 96 (1999) 266-271
29. DeBlasi A., O'Reilly K., and Motulsky H.J. Calculating receptor number from binding experiments using same compound as radioligand and competitor. Trends Pharmacol. Sci. 10 (1989) 227-229
30. Maglich J.M., Stoltz C.M., Goodwin B., Hawkins-Brown D., Moore J.T., and Kliewer S.A. Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol. Pharmacol. 62 (2002) 638-646
31. Rosenfeld J.M., Vargas Jr. R., Xie W., and Evans R.M. Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor. Mol. Endocrinol. 17 (2003) 1268-1282
32. Xue Y., Chao E., Zuercher W.J., Willson T.M., Collins J.L., and Redinbo M.R. Crystal structure of the PXR-T1317 complex provides a scaffold to examine the potential for receptor antagonism. Bioorg. Med. Chem. Lett. 15 (2007) 2156-2166